Projected Sales Volume: Creative Medical Technology Holdings (CELZ)

The future sales level of Creative Medical Technology (CELZ) reflects market expectations for the company. This trend is driven by the implementation of StemSpine for tissue regeneration and the treatment of dysfunctions. The environmental focus is confirmed by the use of energy-efficient reactors and strict control of bio-waste. Stability is supported by functional cryostorage facilities and planned capacity utilization. The value of 0.00 captures the current indicator level, helping investors adjust their portfolios in a timely manner.

Creative Medical Technology - CELZ Company Projected Revenue Volume (period 07/04/2022 - 11/13/2026)

Analytical breakdowns for Creative Medical Technology Holdings Inc. (CELZ)

- stock quotes and analyst forecast:

Stock Price Creative Medical Technology|CELZ - Average Forecast Price

- company stock exchange capitalization indicators:

Market Capitalization Creative Medical Technology Holdings, Inc.|CELZ - Enterprise Value

- book capitalization information:

Accounting Value per Share Creative Medical Technology|CELZ - Total Net Assets|Market Capitalization to Book Value Ratio creativemedicaltechnology.com|CELZ - Company Total Asset Base

- company liabilities and liquidity data:

Total Debt to Equity Ratio Creative Medical Technology|CELZ - Long-Term Debt to Equity|Short-Term Debt to Capital Creative Medical Technology|CELZ - Company Cumulative Debt|Debt to Book Value Creative Medical Technology Holdings, Inc.|CELZ - Company Long-Term Loans and Borrowings|Company Short-Term Debt Creative Medical Technology|Quick Ratio creativemedicaltechnology.com

- financial results and valuation multiples details:

CELZ - Company Net Income|Projected Future Earnings Creative Medical Technology|CELZ - Price to Earnings Multiple|Forward P/E Multiple Creative Medical Technology|CELZ - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Creative Medical Technology Holdings, Inc.|CELZ - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Creative Medical Technology|CELZ - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months creativemedicaltechnology.com|CELZ - Earnings per share growth in current year|Expected earnings per share growth for next year Creative Medical Technology

- company sales and revenue statistics:

CELZ - Company Sales Revenue|Company Future Sales Volume Creative Medical Technology|CELZ - Market Cap to Sales Volume|Forward P/S Multiple Creative Medical Technology Holdings, Inc.

Analysis of all company metrics:Creative Medical Technology Holdings CELZ

Product sample of Creative Medical Technology Holdings Inc.

Fundamental asset selection requires prioritizing objective reporting data over subjective forecasts. This indicator measures the actual dynamics of commercial flows, excluding management rhetoric to assess business sustainability. For Creative Medical Technology (CELZ), this reflects the adoption rate of regenerative technologies in clinical practice. Growth in this metric confirms the commercialization of stem cell therapy. By analyzing the company's sales targets, an investor determines the boundaries of capital safety.

Direct competitors